Mr Mrs Miss Ms Dr Other

Dr
Christopher
Mellor

Patent Director

Edinburgh Office

Chemistry

Telephone. +44(0) 131 220 7500
Mobile. +44(0) 758 447 7868
Email. [email protected]
UPC Representative
Our team of specialist European patent litigators, oppositions specialists and patent attorneys bring together an extensive depth of legal and technical knowledge and are qualified to represent you in the UPC.

Experience

Chris has more than eight years’ experience in the patent profession, specialising in the field of chemistry, particularly medical devices, polymers, biochemistry, pharmaceuticals and surface chemistry. As well as drafting and prosecuting patent applications, he handles contentious EPO opposition and appeal proceedings, provides strategic advice on IP portfolios, and opinions on the infringement and validity of patents.

Qualifications

Patent Attorney

Chartered (UK)
Europe


MCHEM

University of Oxford

PHD

University of Oxford

Recognition

MIP IP Rising Stars 2019/20

The guide highlights the best-performing non-partners who have contributed to the success of their firms and clients in recent years. Results are based on the information, including client feedback and peer responses obtained during the research for the 2019/20 edition of IP Stars.

View recognition online

Publications

Managing IP's Rising Stars 2021

View publication online

MIP IP Rising Stars 2020/2021

View publication online

MIP IP Rising Stars 2019/20

View publication online

Related News

EPO Annual Fee Increases

The European Patent Office (EPO) has announced that revised Official Fees will apply to payments made on or after Monday 1st April 2024. The majority of fees will increase by …

Read article
Event - 30th January 2024

CAR-TCR Summit, Europe 2024

HGF are proud Event Partners of CAR-TCR Europe, which is due to go ahead from 27th – 29th February at ExCeL, Royal Victoria Dock in London. This is the European hub …

Event details

First CRISPR therapy approved for use in the UK

In an unprecedented move, the MHRA has approved a CRISPR gene editing therapy ‘Casgevy’  for the treatment of sickle cell disease and beta-thalassaemia in patients with recurrent vaso-occlusive crises. The Casgevy …

Read article
Event - 8th, 22nd February 2024

Dresden & Salzburg Seminar: Invention and patent searches in public databases

HGF is pleased to invite you to our upcoming German-language seminar on “Invention and patent searches in public databases” in Salzburg and Dresden. The seminar will showcase how public databases …

Event details
Event - 29th November 2023

HGF & Shiga Webinar Recording: Medical devices and bioinformatics / AI diagnostic feedback - law and practice in Europe and Japan

“Medical devices and bioinformatics / AI diagnostic feedback – law and practice in Europe and Japan” The EPC does not allow ‘medical use’ claims for medial devices. So how do …

Event details

Blog Series: IP Ingredients, Part 1: Can you patent a recipe?

A patent is a legal right that enables the patent holder to prevent others from making and using their invention in the country where the patent is granted.  To many …

Read article

UPC and Forum Shopping – Rule 17.3

Order of the classifications listed on the front of a patent and why it matters? On 1 June 2023, ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE lodged a statement of revocation of …

Read article
Event - 16th November 2023

Webinar in cooperation with the BVIZ: Licensing and Technology Transfer

HGF is pleased to invite you to our upcoming German-language webinar in cooperation with the BVIZ on “In- and Out-licensing of Technologies” on 16th of November 2023. The webinar will …

Event details

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.